IRIS
TONINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 19.900
NA - Nord America 4.359
EU - Europa 1.926
SA - Sud America 1.194
AF - Africa 129
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 2
Totale 27.575
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.437
US - Stati Uniti d'America 4.118
CN - Cina 2.255
HK - Hong Kong 2.242
BR - Brasile 913
GB - Regno Unito 631
VN - Vietnam 497
IT - Italia 397
DE - Germania 273
IN - India 146
CA - Canada 134
AR - Argentina 121
NL - Olanda 102
FI - Finlandia 82
MX - Messico 76
ZA - Sudafrica 72
ID - Indonesia 66
AU - Australia 54
EC - Ecuador 51
JP - Giappone 50
TR - Turchia 50
ES - Italia 48
UA - Ucraina 48
PL - Polonia 45
FR - Francia 43
CZ - Repubblica Ceca 36
BD - Bangladesh 34
SE - Svezia 27
CO - Colombia 26
EE - Estonia 24
RU - Federazione Russa 23
PE - Perù 22
CH - Svizzera 21
PY - Paraguay 21
LT - Lituania 17
BE - Belgio 15
BG - Bulgaria 15
CL - Cile 15
VE - Venezuela 14
KR - Corea 13
AT - Austria 12
UZ - Uzbekistan 11
EG - Egitto 9
IL - Israele 9
RO - Romania 9
SA - Arabia Saudita 9
TW - Taiwan 9
IQ - Iraq 7
SI - Slovenia 7
TH - Thailandia 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
HU - Ungheria 6
MA - Marocco 6
PH - Filippine 6
DO - Repubblica Dominicana 5
IE - Irlanda 5
KW - Kuwait 5
PK - Pakistan 5
PT - Portogallo 5
AL - Albania 4
BY - Bielorussia 4
DM - Dominica 4
GT - Guatemala 4
IR - Iran 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
DZ - Algeria 3
ML - Mali 3
NI - Nicaragua 3
NO - Norvegia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AQ - Antartide 2
BB - Barbados 2
BF - Burkina Faso 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
GA - Gabon 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LU - Lussemburgo 2
MK - Macedonia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 27.531
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.227
Singapore 1.581
Hefei 1.202
Ashburn 940
Boardman 702
London 555
Dallas 457
Shanghai 406
Beijing 317
Ho Chi Minh City 199
Los Angeles 151
San Francisco 138
Munich 134
Council Bluffs 128
São Paulo 107
Hanoi 93
Pune 84
Seattle 84
Rome 77
Toronto 77
Santa Clara 66
New York 64
Amsterdam 62
Washington 62
Turku 50
Warsaw 43
Johannesburg 42
Mexico City 41
Rio de Janeiro 41
Tokyo 39
Brno 34
Brooklyn 33
Montreal 32
Helsinki 31
Melbourne 31
Chicago 30
Milan 25
Chennai 24
Boston 22
Naples 22
Stockholm 22
Buenos Aires 21
Da Nang 21
Thái Bình 21
Guayaquil 20
Belo Horizonte 17
Atlanta 16
Phoenix 16
Secaucus 16
Haiphong 15
Quito 15
Porto Alegre 14
West Jordan 14
Ankara 13
Biên Hòa 13
Burgas 13
Hanover 13
Lima 13
Boydton 12
Brasília 12
Canberra 12
Charlotte 12
Denver 12
Hasselt 12
Manchester 12
Poplar 12
Ribeirão Preto 12
St Louis 12
Asunción 11
Sydney 11
Tashkent 11
Curitiba 10
Guangzhou 10
Padova 10
Sona 10
Fortaleza 9
Hải Dương 9
Lấp Vò 9
Maceió 9
Manaus 9
Salvador 9
The Dalles 9
Thái Nguyên 9
Central 8
Haikou 8
Jakarta 8
Las Vegas 8
Ninh Bình 8
Osasco 8
Redmond 8
San Jose 8
Xi'an 8
Buffalo 7
Campinas 7
Campobasso 7
Joinville 7
Juiz de Fora 7
Madrid 7
New Delhi 7
Oklahoma City 7
Totale 11.139
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 245
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 229
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 220
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 217
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 216
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 210
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer 209
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 207
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 206
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 206
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 205
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease 204
Early impairment of food intake in patients newly diagnosed with cancer 203
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 202
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation 201
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 199
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 198
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 196
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 195
Premetastatic niche: ready for new therapeutic interventions? 194
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 194
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 194
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 194
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 193
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 191
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 189
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 187
Prevention of radiotherapy-induced emesis 185
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 184
[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy 184
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 184
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 183
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 182
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 182
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 181
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 179
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 178
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 175
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 173
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 173
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 172
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 171
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 169
Docetaxel induced pericardial effusion 165
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 156
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 141
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 125
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 120
A giant sarcoma of the parotid gland: A case report and review of the literature 119
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 114
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 114
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 110
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 110
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 109
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 108
Colorectal carcinomas and PTEN/MMAC1 gene mutations 105
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 105
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 104
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 103
'Old' and 'new' drugs for the treatment of cancer pain 102
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 100
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 100
A pathology-based combined model to identify pam50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer 100
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study 99
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 98
[Neoplastic hypercalcemia]. 97
Biological effects of cabozantinib on bone microenvironment 97
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 96
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 96
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 95
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 95
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 94
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 94
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 93
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 93
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report 93
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 93
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 93
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 92
Cerebellar metastasis from pancreatic adenocarcinoma. A case report 92
Idiosyncratic reaction after oxaliplatin infusion 92
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 92
Azygo-tracheal fistula in a complete implantable central venous system 92
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 92
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 92
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 92
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 91
A form to report pain assessment and monitoring in the oncology clinical record: a Delphi process 91
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 91
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. 91
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 91
An omental mass: any hypothesis? 90
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 90
Atypical chronic head and neck pain: don't forget Eagle's syndrome 90
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 90
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 89
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 89
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 89
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 87
Large abdominal mass in Crohn's disease 86
Totale 14.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 253.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022839 0 5 8 11 63 5 6 5 20 22 19 675
2022/2023202 22 7 3 19 9 8 18 18 12 1 76 9
2023/20242.026 46 228 137 146 186 872 21 131 26 67 78 88
2024/202519.040 311 224 781 138 150 472 324 79 1.660 1.529 6.204 7.168
2025/20265.620 1.669 739 1.263 1.949 0 0 0 0 0 0 0 0
Totale 27.727